Scientific Advisory Board


Allan Gibofsky, MD, JD

Dr. Gibofsky is Professor of Medicine and Public Health at Weill Medical College of Cornell University, and Professor of Law at Fordham University. He is an Attending Physician and Rheumatologist at both New York Presbyterian Hospital and Hospital for Special Surgery, where he is co-Director of the Clinic for Inflammatory Arthritis.

Dr. Gibofsky received his undergraduate degree from Brooklyn College of the City University of New York, his MD from Weill Medical College of Cornell University and his law degree from Fordham University. He did his internship in Pathology, followed by a residency in Medicine at New York Hospital. He completed a fellowship in Rheumatology/Immunology jointly at Hospital for Special Surgery under Dr. Charles L. Christian, and at The Rockefeller University, where he worked in the laboratory of Dr. Henry G. Kunkel. Dr. Gibofsky has authored or co-authored numerous papers and text chapters, primarily on the immunogenetics of rheumatic diseases and legal aspects of medical practice. He is known for his work on mechanisms of host-microbe interactions in rheumatology, and, in particular for his basic and clinical studies on rheumatic fever.

Currently Secretary-Treasurer of The New York Rheumatism Association, Dr. Gibofsky is past-Chair of the Medical & Scientific Committee of the New York Chapter of The Arthritis Foundation and received their Physicians’ Leadership Award. He also served as a member of the local and national Arthritis Foundation Board of Trustees, and was Chair for Professional Education. Dr. Gibofsky has participated in numerous professional and public education programs, nationally and internationally. Dr. Gibofsky has held numerous leadership and officer positions in the American College of Rheumatology, and served as its President. Dr. Gibofsky is a Managing Director of The Rheumatology Education Group (TREG) LLC, a consortium of experts in the fields of rheumatology, musculoskeletal medicine and pain management.

Dr. Gibofsky’s civic activities include membership on the Brooklyn College Foundation Board of Trustees. He is a Jonas Salk Scholar of the City University and an Alumnus of the Year by Brooklyn College. He is a past president of the American College of Legal Medicine, past Chair of the American Board of Legal Medicine, and past-Chair of the Arthritis Advisory Committee to the Food and Drug Administration.

Robert A. Terkeltaub, MD

Robert A. Terkeltaub, MD is a leading physician-scientist in the fields of arthritis and gout and other crystal diseases. Dr. Terkeltaub received his medical degree at McGill University in Montreal and completed his residency and specialty training in Internal Medicine and Clinical Rheumatology at Montreal General Hospital. He is Board-certified in Internal Medicine and Rheumatology. He is currently Professor of Medicine in the Rheumatology/Allergy/Immunology Division at the University of California San Diego (UCSD). Prior to his appointment at UCSD in 1985, he was associated with the Department of Immunology at the Scripps Research Institute.

Dr. Terkeltaub’s research focuses principally on gout, calcification, and osteoarthritis, and interfaces between metabolism and inflammation. An overview of his research can be viewed at He has been the principal investigator on multiple clinical trials related to gout, including late-stage studies that have led to marketing approvals by the Food and Drug Administration (FDA). His research has been funded for more than 30 years by continuous peer-reviewed grants, and he has been the recipient of numerous professional and teaching awards. Dr. Terkeltaub regularly serves on Study Sections for the National Institutes of Health (NIH) and the Arthritis Research Foundation.

He is currently Co-Editor of the journal, Arthritis and Rheumatology. He has published more than 130 original peer-reviewed papers and authored more than 90 editorials, reviews, and book chapters. He is Editor of the 2 textbooks on gout and was senior and corresponding author of the 2012 gout management guidelines manuscripts for the American College of Rheumatology. Dr. Terkeltaub is inaugural President of G-CAN, the global Gout, hyperuricemia and Crystal Arthropathy research collaborative Network.